G

Goldline Pharmaceutical Ltd.

SME
ListedListed on 19 May 2026+39.0%

Price Range

₹41–43

Issue Size

₹ 8 Cr

Lot Size

6000 Shares

Min. Investment

₹ 2,46,000

Financial Summary

(in crores)
ParticularsFY 2024-25FY 2023-24
Operating Revenue2,805.572,356.6
Other Income00
Total Income2,805.572,356.6
Total Expenses2,199.981,926.18
Profit Before Tax385.84252.69
Total Profit283.42180.6

Subscription Details

781.85xTotal
Subscription
Retail
881.15x
NII - Small
0.00x
NII - Big
0.00x
QIB
180.22x
Employees
0.00x

IPO Timeline

IPO Offer Start

12 May 2026

IPO Offer Ends

14 May 2026

Listing Date

19 May 2026

Use of Proceeds

#PurposeAmount (₹ Cr)
1Prepayment or repayment of all or a portion of certain outstanding borrowings availed by our company83.545
2General corporate purposes 17.055

Promoters

Amol Laxmikant MujumdarSwapan Premprakash Khandelwal

Promoter Shareholding

Pre-IPO

79.70%

Promoter stake

Post-IPO

57.29%

Promoter stake

Offered to Public

19,68,000

shares

Post Share Capital

54,99,982

shares

About the Company

We are engaged in the business of marketing pharmaceutical products under the brand name “Goldline.” Our product portfolio is organized into five distinct segments: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Wellness. The pharmaceutical products marketed under the “Goldline” brand are not manufactured by our Company. Instead, we enter into contractual arrangements with third-party manufacturers, who produce the products based on our market research, demand analysis, and specifications. These contractual arrangements ensure that all products meet the requisite quality standards and regulatory norms.The products are marketed and sold exclusively under the “Goldline” brand. Our customers primarily comprise distributors, who further supply to retailers and wholesalers, forming the main channel of distribution to the end-users. Presently, we maintain contractual arrangements with 15 manufacturers and 7 distributors, ensuring a stable supply chain and consistent market presence.Our Company also extend comprehensive material supply and procurement support to hospitals and healthcare partners. Through our promoter group entities as Numerius Healthcare Pvt Ltd (Formerly Known As Enrich Healthcare & PSPL International) & Activista Healthcare Pvt Ltd (Formerly Known As Gold N Gold Distributors). Our Company manage trading and supply chain operations, thereby ensuring reliable procurement, seamless distribution, and logistical efficiency.Our Promoters, Mr. Amol Laxmikant Mujumdar and Mr. Swapan Premprakash Khandelwal, with 25 years and 30 years of experience respectively in pharmaceutical marketing and supply chain management, have been instrumental in shaping the growth and strategic direction of the Company. Their expertise continues to drive our business expansion and operational resilience.

Use of Proceeds

1. Prepayment or repayment of all or a portion of certain outstanding borrowings availed by our Company; and2. General corporate purposes.